Gony M - Search Results

1

Décisier M, Duhalde V, Faure P, Ammoury A, Gony M, Moreau J, Montastruc JL, Bagheri H. Décisier M, et al. Among authors: gony m. Gut. 2009 Jan;58(1):67, 125. doi: 10.1136/gut.2008.156737. Gut. 2009. PMID: 19091830 No abstract available.

2

Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.

Gony M, Lapeyre-Mestre M, Montastruc JL; French Network of Regional Pharmacovigilance Centers. Gony M, et al. Clin Neuropharmacol. 2003 May-Jun;26(3):142-5. doi: 10.1097/00002826-200305000-00007. Clin Neuropharmacol. 2003. PMID: 12782916 Review.

3

[Meningococcal serogroup C vaccine: a pharmacovigilance point of view].

Bagheri H, Gony M, Montastruc JL. Bagheri H, et al. Among authors: gony m. Therapie. 2005 May-Jun;60(3):287-94. doi: 10.2515/therapie:2005038. Therapie. 2005. PMID: 16130227 French.

4

[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data].

Montastruc JL, Lapeyre-Mestre M, Gony M, Lugardon S, Bagheri H. Montastruc JL, et al. Among authors: gony m. Therapie. 2004 Mar-Apr;59(2):201-5. doi: 10.2515/therapie:2004039. Therapie. 2004. PMID: 15366126 Review. French.

5

[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance].

Montastruc JL, Sommet A, Olivier P, Bagheri H, Gony M, Lapeyre-Mestre M, Brefel-Courbon C, Ferreira J, Schmitt L, Senard JM, Rascol O. Montastruc JL, et al. Among authors: gony m. Therapie. 2006 Jan-Feb;61(1):29-38. doi: 10.2515/therapie:2006011. Therapie. 2006. PMID: 16792152 French.

6

[Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities].

Jacquot J, Gony M, Baudrin D, Chastel X, Montastruc JL, Bagheri H. Jacquot J, et al. Among authors: gony m. Therapie. 2012 May-Jun;67(3):231-6. doi: 10.2515/therapie/2012017. Epub 2012 Aug 9. Therapie. 2012. PMID: 22874489 French.

7

Lacosamide-induced personality changes: An unexpected adverse effect.

Hamard J, Rigal M, Gony M, Bagheri H. Hamard J, et al. Among authors: gony m. Fundam Clin Pharmacol. 2022 Feb;36(1):224-226. doi: 10.1111/fcp.12692. Epub 2021 Jun 5. Fundam Clin Pharmacol. 2022. PMID: 33960008

8

Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.

Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, Montastruc JL, Bagheri H. Gony M, et al. Drug Saf. 2010 May 1;33(5):409-16. doi: 10.2165/11319170-000000000-00000. Drug Saf. 2010. PMID: 20397740

9

[Amiodarone or COVID induced-pneumopathy: One train can hide another one!].

Vasseur M, Tambon M, Gony M, Lebrun N, Bagheri H. Vasseur M, et al. Among authors: gony m. Therapie. 2021 Jul-Aug;76(4):374-377. doi: 10.1016/j.therap.2021.03.001. Epub 2021 Mar 6. Therapie. 2021. PMID: 33722418 Free PMC article. French. No abstract available.

10

Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users.

Lapeyre-Mestre M, Llau ME, Gony M, Navel AM, Bez J, Grau M, Montastruc JL. Lapeyre-Mestre M, et al. Among authors: gony m. Drug Alcohol Depend. 2003 Dec 11;72(3):297-303. doi: 10.1016/j.drugalcdep.2003.08.005. Drug Alcohol Depend. 2003. PMID: 14643947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters